Literature DB >> 8183432

Metabotropic ATP receptor in hippocampal and thalamic neurones: pharmacology and modulation of Ca2+ mobilizing mechanisms.

S L Mironov1.   

Abstract

Changes in cytoplasmic free Ca2+ concentration, [Ca]i, elicited by ATP, were studied in neurones cultured from rat hippocampus and thalamus. ATP evoked [Ca]i increases in about 30% of all cells tested and suppressed [Ca]i transients in responsive cells. The number of responses to ATP markedly increased after pretreatment of cells with inhibitors of protein kinase C, H-7 or staurosporine. The potentiation was blocked by a phorbol ester and by dioleylglycerol. In pretreated cells both once peak [Ca]i and the number of successive trials were augmented by an [ATP] increase. The former effect can be described by the Michaelis-Menten equation whereas the latter one has a steeper, leftward-shifted dependence. Both concentration dependences are explained with a model, describing Ca2+ release as a threshold phenomena. ATP analogues had the rank of potency: ATP approximately ADP >> AMP > alpha, beta-MeATP. A single ATP application depleted internal Ca2+ stores which could be replenished by brief membrane depolarization with high-K+. ATP- and caffeine-induced [Ca]i transients were independent, indicating two non-overlapping Ca2+ storage sites. Only caffeine effects were potentiated at an elevated [Ca]i level, showing a Ca(2+)-induced Ca2+ release. Inhibitors of the Ca2+ pump in internal stores, ryanodine and sulphydryl reagents suppressed the ATP-induced [Ca]i transients, acting via different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183432     DOI: 10.1016/0028-3908(94)90091-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

Review 1.  Nucleotide receptors in the nervous system. An abundant component using diverse transduction mechanisms.

Authors:  E A Barnard; J Simon; T E Webb
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

Review 2.  Novel vistas of calcium-mediated signalling in the thalamus.

Authors:  Hans-Christian Pape; Thomas Munsch; Thomas Budde
Journal:  Pflugers Arch       Date:  2004-02-10       Impact factor: 3.657

3.  Effect of P2-purinoceptor antagonists on glutamatergic transmission in the rat hippocampus.

Authors:  L Motin; M R Bennett
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

4.  Implications of purinergic receptor-mediated intracellular calcium transients in neural differentiation.

Authors:  Talita Glaser; Rodrigo R Resende; Henning Ulrich
Journal:  Cell Commun Signal       Date:  2013-02-17       Impact factor: 5.712

5.  New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders.

Authors:  Paromita Majumder; Cleber A Trujillo; Camila G Lopes; Rodrigo R Resende; Katia N Gomes; Katia K Yuahasi; Luiz R G Britto; Henning Ulrich
Journal:  Purinergic Signal       Date:  2007-09-12       Impact factor: 3.765

6.  Imaging cytoplasmic cAMP in mouse brainstem neurons.

Authors:  S L Mironov; E Skorova; G Taschenberger; N Hartelt; V O Nikolaev; M J Lohse; S Kügler
Journal:  BMC Neurosci       Date:  2009-03-27       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.